Literature DB >> 3405380

Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.

M Castillo1, M F Zafra, E Garcia-Peregrin.   

Abstract

Experimental hyperphenylalaninemia has been induced in 5-day-old chicks by dietary treatments with phenylalanine and alpha-methylphenylalanine. An increase of nearly 8-fold in plasma Phe/Tyr ratio was found after 4 days of supplementation the standard diet with 5% phenylalanine plus 0.4% alpha-methylphenylalanine. The increase in this ratio was about 13-fold after 9 days of the same treatment. Similar results were observed in brain and liver, although the increases were smaller than those found in plasma. Total body, brain and liver weight decreased after 9 days of treatment. Phenylalanine plus alpha-methylphenylalanine administration to 5-day-old chicks produced a significant decrease in the 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase specific activities from both brain and liver. These results demonstrated for the first time that experimental hyperphenylalaninemia inhibited different enzyme activities directly implicated in the regulation of cholesterogenesis. Therefore, a reduced cholesterol synthesis in brain may evidenciate the theory of an impaired myelination leading to mental retardation in phenylketonuria patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405380     DOI: 10.1007/bf00973296

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  A chemical investigation of the defects of myelination in phenylketonuria.

Authors:  L CROME; V TYMMS; L I WOOLF
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-05       Impact factor: 10.154

2.  Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats.

Authors:  C K Ramachandran; S N Shah
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

3.  Alpha-methylphenylalanine, a new inducer of chronic hyperphenylalaninemia in sucling rats.

Authors:  O Greengard; M S Yoss; J A Del Valle
Journal:  Science       Date:  1976-06-04       Impact factor: 47.728

4.  Induction of experimental phenylketonuria-like conditions in chick embryo. Effect on amino acid concentration in brain, liver and plasma.

Authors:  C Marco; M J Alejandre; M F Zafra; J L Segovia; E Garcia-Peregrin
Journal:  Neurochem Int       Date:  1984       Impact factor: 3.921

5.  Impaired myelin formation in experimental hyperphenylalaninaemia.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  J Neurochem       Date:  1972-02       Impact factor: 5.372

Review 6.  The pathogenesis of mental retardation in phenylketonuria and other inborn errors of amino acid metabolism.

Authors:  J H Menkes
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

7.  Relationship between changes in free cholesterol and pyrophosphomevalonate decarboxylase activity during myelination.

Authors:  C Marco; D Gonzalez-Pacanowska; A Linares; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1983-06       Impact factor: 3.996

8.  Effect of hyperphenylalaninemia on amino acid metabolism and compartmentation in neonatal rat brain.

Authors:  E L Nordyke; M K Roach
Journal:  Brain Res       Date:  1974-03-08       Impact factor: 3.252

9.  Different thermal behavior of neonatal hepatic and cerebral 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  H Ramirez; M J Alejandre; J L Segovia; E Garcia-Peregrin
Journal:  Lipids       Date:  1981-07       Impact factor: 1.880

10.  Brain phosphorylation and decarboxylation of mevalonic acid in the neonatal chick.

Authors:  D Gonzalez-Pacanowska; J García-Martinez; E García-Peregrín
Journal:  Enzyme       Date:  1981
View more
  18 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Coenzyme-Q(10) concentration in human phenylketonuria.

Authors:  R Artuch; M A Vilaseca; N Lambruschini; J Campistol
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 3.  Oxidative stress in phenylketonuria: future directions.

Authors:  Júlio César Rocha; Maria João Martins
Journal:  J Inherit Metab Dis       Date:  2011-11-25       Impact factor: 4.982

4.  Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients.

Authors:  Burcu Kumru; Davut Sinan Kaplan; Burcu Oztürk Hismi; Hakim Celik
Journal:  Cell Mol Neurobiol       Date:  2017-12-28       Impact factor: 5.046

5.  Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients.

Authors:  I P Hargreaves; S J R Heales; A Briddon; J M Land; P J Lee
Journal:  J Inherit Metab Dis       Date:  2002-12       Impact factor: 4.982

6.  Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria.

Authors:  R Artuch; C Colomé; M A Vilaseca; C Sierra; F J Cambra; N Lambruschini; J Campistol
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

7.  Phenylketonuria: an inborn error of phenylalanine metabolism.

Authors:  Robin A Williams; Cyril D S Mamotte; John R Burnett
Journal:  Clin Biochem Rev       Date:  2008-02

8.  Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia.

Authors:  N Kyprianou; E Murphy; P Lee; I Hargreaves
Journal:  J Inherit Metab Dis       Date:  2009-03-13       Impact factor: 4.982

9.  Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis.

Authors:  M Castillo; M Martinez-Cayuela; M F Zafra; E Garcia-Peregrin
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

10.  Metabolomics of dietary fatty acid restriction in patients with phenylketonuria.

Authors:  Ulrike Mütze; Skadi Beblo; Linda Kortz; Claudia Matthies; Berthold Koletzko; Mathias Bruegel; Carmen Rohde; Joachim Thiery; Wieland Kiess; Uta Ceglarek
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.